Hjem › Skizofreni › Ohio
Skizofreni kliniske forsøg i Ohio
18 studier for Skizofreni søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
Safety and Tolerability of Open-Labeled Iloperidone in Adolescents
- Vanda Investigational Site, Cincinnati
- Vanda Investigational Site, Garfield Heights
- Vanda Investigational Site, Westlake
RekruttererFase 4
Alder 12 til 17 · Alle køn · Opdateret 1. okt. 2026 · NCT05648591Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)
- Westlake Brain Health, Westlake
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07101094Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Local Institution - 0183, Cincinnati
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 28. sep. 2026 · NCT07686263Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
- University of Cincinnati Medical Center, Cincinnati
- Charak Center for Health and Wellness, Garfield Heights
RekruttererFase 3
Alder 5 til 17 · Alle køn · Opdateret 25. sep. 2026 · NCT06229210NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
- Neurocrine Clinical Site, North Canton
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT07105098NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
- Neurocrine Clinical Sites, North Canton
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 25. sep. 2026 · NCT07114874A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- University of Cincinnati Cancer Institute, Cincinnati
- Local Institution - 0148, Cincinnati
RekruttererFase 3
Alder 5 til 17 · Alle køn · Opdateret 22. sep. 2026 · NCT07424404A Study of Brenipatide in Adult Participants With Schizophrenia
- Insight Clinical Trials, Independence
RekruttererFase 2
Alder 18 til 55 · Alle køn · Opdateret 22. sep. 2026 · NCT07410507A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Independence
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT0710511152-week Open Label Safety-Tolerability Study
- Neuro-Behavioral Clinical Research, Canton
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 9. sep. 2026 · NCT07369154A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
- University of Cincinnati Dept of Psychiatry and Behavioral Neuroscience, Cincinnati
RekruttererFase 3
Alder 13 til 17 · Alle køn · Opdateret 4. sep. 2026 · NCT07288567A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Clinical Site, North Canton
- Clinical Site, West Chester
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 1. sep. 2026 · NCT07459647Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
- Local Institution - 0031, Mason
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT07379827REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
- Case Western Reserve University, Cleveland
Rekrutterer
Alder 18 til 50 · Alle køn · Opdateret 17. aug. 2026 · NCT07006935Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
- Alkermes Investigator Site, Cincinnati
- Alkermes Investigator Site, West Chester
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 14. aug. 2026 · NCT05303064Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
- Neuro-Behavioral Clinical Research, North Canton
RekruttererFase 3
Alder 18 til 65 · Alle køn · Opdateret 27. jul. 2026 · NCT07363577A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
- Neuro-Behavioral Clinical Research, North Canton
RekruttererFase 2
Alder 18 til 55 · Alle køn · Opdateret 23. jun. 2026 · NCT07191483Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
- Harding Hospital, Columbus
Rekrutterer
Alder 15 til 35 · Alle køn · Opdateret 25. feb. 2026 · NCT04368039Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.